103 related articles for article (PubMed ID: 1419787)
1. Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function.
Pattanapanyasat K; Webster HK; Tongtawe P; Kongcharoen P; Hider RC
Br J Haematol; 1992 Sep; 82(1):13-9. PubMed ID: 1419787
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 replication inhibition by the bidentate iron chelators CP502 and CP511 is caused by proliferation inhibition and the onset of apoptosis.
Georgiou NA; van der Bruggen T; Oudshoorn M; Hider RC; Marx JJ; van Asbeck BS
Eur J Clin Invest; 2002 Mar; 32 Suppl 1():91-6. PubMed ID: 11886438
[TBL] [Abstract][Full Text] [Related]
4. Iron chelators induce apoptosis in proliferating cells.
Hileti D; Panayiotidis P; Hoffbrand AV
Br J Haematol; 1995 Jan; 89(1):181-7. PubMed ID: 7833261
[TBL] [Abstract][Full Text] [Related]
5. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
6. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
Zevin S; Link G; Grady RW; Hider RC; Peter HH; Hershko C
Blood; 1992 Jan; 79(1):248-53. PubMed ID: 1728313
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
Hoyes KP; Jones HM; Abeysinghe RD; Hider RC; Porter JB
Exp Hematol; 1993 Jan; 21(1):86-92. PubMed ID: 8417963
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of in vitro lymphoproliferation by three novel iron chelators of the pyridoxal and salicyl aldehyde hydrazone classes.
van Reyk D; Sarel S; Hunt N
Biochem Pharmacol; 2000 Aug; 60(4):581-7. PubMed ID: 10874133
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine.
Polson RJ; Jenkins R; Lombard M; Williams AC; Roberts S; Nouri-Aria K; Williams R; Bomford A
Immunology; 1990 Oct; 71(2):176-81. PubMed ID: 2228020
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators in leukemia cell lines.
Hoyes KP; Hider RC; Porter JB
Cancer Res; 1992 Sep; 52(17):4591-9. PubMed ID: 1511427
[TBL] [Abstract][Full Text] [Related]
11. Effect of desferrioxamine and deferiprone (L1) on the proliferation of MG-63 bone cells and on phosphatase alkaline activity.
Naves Díaz ML; Elorriaga R; Canteros A; Cannata Andía JB
Nephrol Dial Transplant; 1998; 13 Suppl 3():23-8. PubMed ID: 9568816
[TBL] [Abstract][Full Text] [Related]
12. The antimalarial effect of iron chelators: studies in animal models and in humans with mild falciparum malaria.
Hershko C; Gordeuk VR; Thuma PE; Theanacho EN; Spira DT; Hider RC; Peto TE; Brittenham GM
J Inorg Biochem; 1992 Aug 15-Sep; 47(3-4):267-77. PubMed ID: 1431886
[TBL] [Abstract][Full Text] [Related]
13. The effect of iron and transferrin on the response of serum-free cultures of mouse lymphocytes to concanavalin A and lipopolysaccharide.
Brock JH
Immunology; 1981 Jun; 43(2):387-92. PubMed ID: 7251059
[TBL] [Abstract][Full Text] [Related]
14. Effect of transferrin, lactoferrin and chelated iron on human T-lymphocytes.
Djeha A; Brock JH
Br J Haematol; 1992 Feb; 80(2):235-41. PubMed ID: 1550782
[TBL] [Abstract][Full Text] [Related]
15. Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes.
Djeha A; Brock JH
Biochim Biophys Acta; 1992 Jan; 1133(2):147-52. PubMed ID: 1731957
[TBL] [Abstract][Full Text] [Related]
16. Effect of an iron-chelating agent on lymphocyte proliferation.
Bowern N; Ramshaw IA; Badenoch-Jones P; Doherty PC
Aust J Exp Biol Med Sci; 1984 Dec; 62 ( Pt 6)():743-54. PubMed ID: 6241825
[TBL] [Abstract][Full Text] [Related]
17. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
Hershko C; Link G; Pinson A; Peter HH; Dobbin P; Hider RC
Blood; 1991 May; 77(9):2049-53. PubMed ID: 2018841
[TBL] [Abstract][Full Text] [Related]
18. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Le NT; Richardson DR
Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
[TBL] [Abstract][Full Text] [Related]
19. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats.
Zanninelli G; Choudury R; Loréal O; Guyader D; Lescoat G; Arnaud J; Verna R; Cosson B; Singh S; Hider RC; Brissot P
J Hepatol; 1997 Jul; 27(1):176-84. PubMed ID: 9252093
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines.
Kontoghiorghes GJ; Piga A; Hoffbrand AV
Hematol Oncol; 1986; 4(3):195-204. PubMed ID: 3095210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
